Pharmaserve

Founded in April 1984 by Dionysios Filiotis, a distinguished pharmacist, Pharmaserve has been guided by unwavering principles of integrity and excellence from its inception. Our commitment to delivering high-quality healthcare solutions to the Greek populace has been our motivating force. Initially established as the exclusive distributor for the pharmaceutical giant Eli Lilly in Greece, Pharmaserve transitioned into a joint venture with Eli Lilly in 1994. This alliance, known as Pharmaserve-Lilly, solidifies our position as Eli Lilly’s strategic partner in the Greek market to this day. Over the years, our dedication to excellence, ethical conduct, integrity, and diligence has elevated Pharmaserve into a trusted collaborator within Greece’s healthcare community. We are widely recognized as one of the country’s most impactful healthcare companies. Our robust portfolio of high-quality healthcare products is developed through strategic partnerships with healthcare companies, both in Greece and globally, in order to best serve the healthcare needs of the Greek populace. We are steadily strengthening our presence in consumer products, in medical technology products, and in innovative and well-established pharmaceutical products of the highest quality that offer options to patients to treat a number of illnesses and to improve quality of life. We prioritize transparency in our operations. We rigorously adhere to procedures for transparent disclosure of benefits to healthcare professionals, in compliance with the guidelines set forth by the National Organization for Medicines. We emphasize transparency. We apply procedures for transparency and disclosure of benefits to third-party Health Professionals, in accordance with the provisions of the National Organization for Medicines. Pharmaserve boasts an unparalleled legacy in clinical research, commercialization and distribution of healthcare products throughout Greece.